Miller AE - Search Results

1

Detection of subtle gait disturbance and future fall risk in early multiple sclerosis.

Brandstadter R, Ayeni O, Krieger SC, Harel NY, Escalon MX, Katz Sand I, Leavitt VM, Fabian MT, Buyukturkoglu K, Klineova S, Riley CS, Lublin FD, Miller AE, Sumowski JF. Brandstadter R, et al. Among authors: miller ae. Neurology. 2020 Mar 31;94(13):e1395-e1406. doi: 10.1212/WNL.0000000000008938. Epub 2020 Feb 26. Neurology. 2020. PMID: 32102980 Free PMC article.

2

Management of patients receiving interferon beta-1b for multiple sclerosis: report of a consensus conference.

Lublin FD, Whitaker JN, Eidelman BH, Miller AE, Arnason BG, Burks JS. Lublin FD, et al. Among authors: miller ae. Neurology. 1996 Jan;46(1):12-8. doi: 10.1212/wnl.46.1.12. Neurology. 1996. PMID: 8559358 Review.

3

A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis.

Miller AE, Morgante LA, Buchwald LY, Nutile SM, Coyle PK, Krupp LB, Doscher CA, Lublin FD, Knobler RL, Trantas F, Kelley L, Smith CR, La Rocca N, Lopez S. Miller AE, et al. Neurology. 1997 Feb;48(2):312-4. doi: 10.1212/wnl.48.2.312. Neurology. 1997. PMID: 9040712 Clinical Trial.

4

Development of a multiple sclerosis functional composite as a clinical trial outcome measure.

Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, Syndulko K, Weinshenker BG, Antel JP, Confavreux C, Ellison GW, Lublin F, Miller AE, Rao SM, Reingold S, Thompson A, Willoughby E. Cutter GR, et al. Among authors: miller ae. Brain. 1999 May;122 ( Pt 5):871-82. doi: 10.1093/brain/122.5.871. Brain. 1999. PMID: 10355672

5

Are quantitative functional measures more sensitive to worsening MS than traditional measures?

Schwid SR, Goodman AD, Apatoff BR, Coyle PK, Jacobs LD, Krupp LB, Miller AE, Wende KE, Brownscheidle CM, New York State Multiple Sclero. Schwid SR, et al. Among authors: miller ae. Neurology. 2000 Dec 26;55(12):1901-3. doi: 10.1212/wnl.55.12.1901. Neurology. 2000. PMID: 11134392

6

Immunotherapy of multiple sclerosis--current practice and future directions.

Tullman MJ, Lublin FD, Miller AE. Tullman MJ, et al. Among authors: miller ae. J Rehabil Res Dev. 2002 Mar-Apr;39(2):273-85. J Rehabil Res Dev. 2002. PMID: 12051470 Free article. Review.

7

Long-term (up to 22 years), open-label, compassionate-use study of glatiramer acetate in relapsing-remitting multiple sclerosis.

Miller A, Spada V, Beerkircher D, Kreitman RR. Miller A, et al. Mult Scler. 2008 May;14(4):494-9. doi: 10.1177/1352458507085029. Epub 2008 Jan 21. Mult Scler. 2008. PMID: 18208875 Clinical Trial.

8

Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment.

Polman CH, Reingold SC, Barkhof F, Calabresi PA, Clanet M, Cohen JA, Cutter GR, Freedman MS, Kappos L, Lublin FD, McFarland HF, Metz LM, Miller AE, Montalban X, O'Connor PW, Panitch H, Richert JR, Petkau J, Schwid SR, Sormani MP, Thompson AJ, Weinshenker BG, Wolinsky JS. Polman CH, et al. Among authors: miller ae. Neurology. 2008 Mar 25;70(13 Pt 2):1134-40. doi: 10.1212/01.wnl.0000306410.84794.4d. Neurology. 2008. PMID: 18362273

9

Dose comparison trial of sustained-release fampridine in multiple sclerosis.

Goodman AD, Brown TR, Cohen JA, Krupp LB, Schapiro R, Schwid SR, Cohen R, Marinucci LN, Blight AR; Fampridine MS-F202 Study Group. Goodman AD, et al. Neurology. 2008 Oct 7;71(15):1134-41. doi: 10.1212/01.wnl.0000326213.89576.0e. Epub 2008 Jul 30. Neurology. 2008. PMID: 18672472 Clinical Trial.

10

Longitudinal correlates of fatigue in multiple sclerosis.

Patrick E, Christodoulou C, Krupp LB; New York State MS Consortium. Patrick E, et al. Mult Scler. 2009 Feb;15(2):258-61. doi: 10.1177/1352458508097466. Mult Scler. 2009. PMID: 19181775

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

242 results

Search Page